These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24475586)

  • 1. Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: report of two cases.
    Cossu A; Paliogiannis P; Capobianco G; Sini MC; Dessole M; Dessole S; Palmieri G
    Eur J Gynaecol Oncol; 2013; 34(5):469-72. PubMed ID: 24475586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study.
    Kosemehmetoglu K; Kaygusuz G; Bahrami A; Raimondi SC; Kilicarslan K; Yildiz Y; Folpe AL
    Am J Surg Pathol; 2011 Jun; 35(6):891-7. PubMed ID: 21566521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers.
    Hammer PM; Kolin DL; Charville GW; McCluggage WG; Howitt BE
    Histopathology; 2022 Sep; 81(3):342-351. PubMed ID: 35758187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
    Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
    Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
    Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
    Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
    Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
    Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
    Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.
    Sakharpe A; Lahat G; Gulamhusein T; Liu P; Bolshakov S; Nguyen T; Zhang P; Belousov R; Young E; Xie X; Rao P; Hornick JL; Lazar AJ; Pollock RE; Lev D
    Oncologist; 2011; 16(4):512-22. PubMed ID: 21357725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
    Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
    Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic determinants in epithelioid sarcoma.
    Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
    Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
    Orrock JM; Abbott JJ; Gibson LE; Folpe AL
    Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B; Jambhekar NA
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression.
    Tajima S; Takahasi Y; Hikoaki M; Goto R
    Int J Clin Exp Pathol; 2015; 8(6):7526-32. PubMed ID: 26261664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.